<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="3-part\PMC7048371\results\search\disease\results.xml">
  <result pre="explicitly solvated, and experimentally based integrative model of the pandemic" exact="influenza" post="A H1N1 2009 viral envelope, containing ∼160 million atoms"/>
  <result pre="into the understanding of substrate recognition processes for this vital" exact="influenza" post="drug target, suggesting a new strategy for the development"/>
  <result pre="of substrate recognition processes for two sialic binding sites of" exact="influenza" post="neuraminidase. Introduction Influenza virus infection is responsible for millions"/>
  <result pre="each year. The Center for Disease Control estimates that pandemic" exact="influenza" post="A H1N1 2009 (pH1N1) affected 60.8 million people, resulting"/>
  <result pre="development of novel approaches for the prevention and treatment of" exact="influenza" post="virus infection. One such strategy is to target the"/>
  <result pre="site was first identified as a hemadsorption site in avian-origin" exact="influenza" post="NAs22−26 and was not initially believed to be present"/>
  <result pre="support for the presence of a 2° site in swine-origin" exact="influenza" post="NAs, including pN1.16,17 The precise mechanism by which this"/>
  <result pre="has recently been identified as a target for a novel" exact="influenza" post="virus inhibitor,33,34 further highlighting the need to understand its"/>
  <result pre="viral glycoproteins. (A) A fully intact all-atom model of the" exact="influenza" post="A H1N1 2009 (pH1N1) viral envelope, containing over 160"/>
  <result pre="Sansom and colleagues in 2015 reported an explicitly solvated CG" exact="influenza" post="virus simulation (∼80 nm diameter, 5 million particles).48 In"/>
  <result pre="2018; Vol. 11, pp. 7–10. WangX.; et al. Epidemiology of" exact="avian influenza" post="A H7N9 virus in human beings across five epidemics"/>
  <result pre="Vol. 11, pp. 7–10. WangX.; et al. Epidemiology of avian" exact="influenza" post="A H7N9 virus in human beings across five epidemics"/>
  <result pre="Infect. Dis.2017, 17, 822–832. 10.1016/S1473-3099(17)30323-7.28583578 De ClercqE.Antiviral agents active against" exact="influenza" post="A viruses. Nat. Rev. Drug Discovery2006, 5, 1015–1025. 10.1038/nrd2175.17139286"/>
  <result pre="10.1074/jbc.R110.129809.20538598 AnJ.; et al. A novel small-molecule inhibitor of the" exact="avian influenza" post="H5N1 virus determined through computational screening against the neuraminidase."/>
  <result pre="AnJ.; et al. A novel small-molecule inhibitor of the avian" exact="influenza" post="H5N1 virus determined through computational screening against the neuraminidase."/>
  <result pre="modified C4-substituents as the inhibitors against the group-1 neuraminidases of" exact="influenza" post="viruses. Bioorg. Med. Chem.2010, 18, 4074–4084. 10.1016/j.bmc.2010.04.010.20452227 RudrawarS.; DyasonJ."/>
  <result pre="ItzsteinM.Novel sialic acid derivatives lock open the 150-loop of an" exact="influenza" post="A virus group-1 sialidase. Nat. Commun.2010, 1, 11310.1038/ncomms1114.21081911 AmaroR."/>
  <result pre="7764–7765. 10.1021/ja0723535.17539643 RussellR. J.; et al. The structure of H5N1" exact="avian influenza" post="neuraminidase suggests new opportunities for drug design. Nature2006, 443,"/>
  <result pre="10.1021/ja0723535.17539643 RussellR. J.; et al. The structure of H5N1 avian" exact="influenza" post="neuraminidase suggests new opportunities for drug design. Nature2006, 443,"/>
  <result pre="drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1–2009" exact="influenza" post="virus. Biochemistry2012, 51, 4364–4375. 10.1021/bi300561n.22574858 AmaroR. E.; ChengX.; IvanovI.;"/>
  <result pre="Soc.2009, 131, 4702–4709. 10.1021/ja8085643.19296611 HausmannJ.; KretzschmarE.; GartenW.; KlenkH.-D.N1 neuraminidase of" exact="influenza" post="virus A/FPV/Rostock/34 has haemadsorbing activity. J. Gen. Virol.1995, 76,"/>
  <result pre="C.; et al. A secondary sialic acid binding site on" exact="influenza" post="virus neuraminidase: Fact or fiction?. Angew. Chem., Int. Ed.2012,"/>
  <result pre="LiW. W.; WalkerR. C.; BushR. M.Mechanism of 150-cavity formation in" exact="influenza" post="neuraminidase. Nat. Commun.2011, 2, 38810.1038/ncomms1390.21750542 LiQ.; et al. The"/>
  <result pre="WebsterR. G.; et al. Antigenic structure and variation in an" exact="influenza" post="virus N9 neuraminidase. J. Virol.1987, 61, 2910–6. 10.1128/JVI.61.9.2910-2916.1987.3612957 VargheseJ."/>
  <result pre="Structural evidence for a second sialic acid binding site in" exact="avian influenza" post="virus neuraminidases. Proc. Natl. Acad. Sci. U. S. A.1997,"/>
  <result pre="evidence for a second sialic acid binding site in avian" exact="influenza" post="virus neuraminidases. Proc. Natl. Acad. Sci. U. S. A.1997,"/>
  <result pre="10.1016/j.antiviral.2015.08.014.26364554 KobasaD.; RodgersM. E.; WellsK.; KawaokaY.Neuraminidase hemadsorption activity, conserved in" exact="avian influenza" post="A viruses, does not influence viral replication in ducks."/>
  <result pre="KobasaD.; RodgersM. E.; WellsK.; KawaokaY.Neuraminidase hemadsorption activity, conserved in avian" exact="influenza" post="A viruses, does not influence viral replication in ducks."/>
  <result pre="UhlendorffJ.; MatrosovichT.; KlenkH.-D.; MatrosovichM.Functional significance of the hemadsorption activity of" exact="influenza" post="virus neuraminidase and its alteration in pandemic viruses. Arch."/>
  <result pre="10.1128/JVI.01243-18.30089692 DuW.; et al. The 2nd sialic acid-binding site of" exact="influenza" post="A virus neuraminidase is an important determinant of the"/>
 </snippets>
</snippetsTree>
